AbCellera Biologics Inc. (ABCL) Form 10-K Annual Reports
AbCellera Biologics Inc. (ABCL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ABCL
CIK: 1703057
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerSteven Douglas
Audit LocationVancouver, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-24 | 2026-08-24 | FORM 4 | 0001628280-26-058684 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-18 | FORM 4 | 0001834423-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0001834411-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001628280-26-057007 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-12 | 8-K | 0001193125-26-349353 | View SEC Doc Filr Page |
| 424B5 | 2026-08-13 | — | 424B5 | 0001193125-26-349333 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001628280-26-056653 | View SEC Doc Filr Page |
| 424B5 | 2026-08-11 | — | 424B5 | 0001193125-26-344944 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001703057-26-000053 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | 8-K | 0001703057-26-000049 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001703057-26-000046 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001703057-26-000044 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | 8-K | 0001703057-26-000039 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | FORM 4 | 0001628280-26-047400 | View SEC Doc Filr Page |
| 3 | 2026-07-06 | 2026-06-30 | FORM 3 | 0001628280-26-047399 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | FORM 4 | 0001628280-26-047396 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-06-30 | 8-K | 0001703057-26-000037 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001703057-26-000035 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001628280-26-042739 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001685889-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001834423-26-000006 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | 8-K | 0001703057-26-000033 | View SEC Doc Filr Page |
| 3 | 2026-06-11 | 2026-06-01 | FORM 3 | 0001628280-26-042450 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-01 | 8-K | 0001703057-26-000031 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-03 | FORM 4 | 0001834411-26-000006 | View SEC Doc Filr Page |